Page 124 - Read Online

Page 8 of 9 Yoon. Hepatoma Res 2018;4:42 I http://dx.doi.org/10.20517/2394-5079.2018.23

DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis. J Viral Hepat 2010;17:98-107.
21. Kong G, Zhang J, Zhang S, Shan C, Ye L, Zhang X. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell
migration by targeting PTEN in cell culture model. PLoS One 2011;6:e19518.
22. Rusyn I, Lemon SM. Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies? Cancer Lett
2014;345:210-5.
23. Lerat H, Higgs M, Pawlotsky JM. Animal models in the study of hepatitis C virus-associated liver pathologies. Expert Rev Gastroenterol
Hepatol 2011;5:341-52.
24. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM.
Complete replication of hepatitis C virus in cell culture. Science 2005;309:623-6.
25. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma
cell line. Science 1999;285:110-3.
26. Tacke RS, Tosello-Trampont A, Nguyen V, Mullins DW, Hahn YS. Extracellular hepatitis C virus core protein activates STAT3 in human
monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway. J Biol Chem 2011;286:10847-55.
27. Zhu Z, Wilson AT, Gopalakrishna K, Brown KE, Luxon BA, Schmidt WN. Hepatitis C virus core protein enhances Telomerase activity in
Huh7 cells. J Med Virol 2010;82:239-48.
28. He Q, Cheng R, Chen Z, Xiao X, Xiao Z, Li C, Li B, Zhang P, Zheng H, Feng D. Cell transformation and proteome alteration in QSG7701
cells transfected with hepatitis C virus non-structural protein 3. Acta Biochim Biophys Sin (Shanghai) 2007;39:751-62.
29. Kwun HJ, Jung EY, Ahn JY, Lee MN, Jang KL. p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3. J Gen
Virol 2001;82:2235-41.
30. Yu GY, He G, Li CY, Tang M, Grivennikov S, Tsai WT, Wu MS, Hsu CW, Tsai Y, Wang LH, Karin M. Hepatic expression of HCV RNA-
dependent RNA polymerase triggers innate immune signaling and cytokine production. Mol Cell 2012;48:313-21.
31. Korenaga M, Wang T, Li Y, Showalter LA, Chan T, Sun J, Weinman SA. Hepatitis C virus core protein inhibits mitochondrial electron
transport and increases reactive oxygen species (ROS) production. J Biol Chem 2005;280:37481-8.
32. Munakata T, Nakamura M, Liang Y, Li K, Lemon SM. Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus
NS5B RNA-dependent RNA polymerase. Proc Natl Acad Sci U S A 2005;102:18159-64.
33. Choi SH, Hwang SB. Modulation of the transforming growth factor-beta signal transduction pathway by hepatitis C virus nonstructural 5A
protein. J Biol Chem 2006;281:7468-78.
34. Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, Shen R, Huang Y, Chen HC, Lee CH, Tsai TF, Hsu MT, Wu JC, Huang HD, Shiao MS, Hsiao
M, Tsou AP. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 2012;122:2884-97.
35. Smeenk R, Duin T, Aarden L. Influence of pH on the detection of low- and high-avidity anti-dsDNA. J Immunol Methods 1982;55:361-73.
36. Abbas Z, Abbas M, Abbas S, Shazi L. Hepatitis D and hepatocellular carcinoma. World J Hepatol 2015;7:777-86.
37. Schwartz JM, Reinus JF. Prevalence and natural history of alcoholic liver disease. Clin Liver Dis 2012;16:659-66.
38. Neuman MG, Malnick S, Maor Y, Nanau RM, Melzer E, Ferenci P, Seitz HK, Mueller S, Mell H, Samuel D, Cohen LB, Kharbanda KK,
Osna NA, Ganesan M, Thompson KJ, McKillop IH, Bautista A, Bataller R, French SW. Alcoholic liver disease: clinical and translational
research. Exp Mol Pathol 2015;99:596-610.
39. Plemenitas A, Kastelic M, Porcelli S, Serretti A, Rus Makovec M, Kores Plesnicar B, Dolzan V. Genetic variability in CYP2E1 and catalase
gene among currently and formerly alcohol-dependent male subjects. Alcohol Alcohol 2015;50:140-5.
40. Polonikov AV, Ivanov VP, Solodilova MA. CYP2E1 gene promoter polymorphism -1293G>C increases the risk of essential hypertension in
men with alcohol abuse. Bull Exp Biol Med 2013;155:734-7.
41. Liu W, Tian F, Dai L, Chai Y. Cytochrome P450 2E1 gene polymorphism and alcohol drinking on the risk of hepatocellular carcinoma: a
meta-analysis. Mol Biol Rep 2014;41:7645-50.
42. Schulze K, Imbeaud S, Letouze E, Alexandrov LB, Calderaro J, Rebouissou S, Couchy G, Meiller C, Shinde J, Soysouvanh F, Calatayud
AL, Pinyol R, Pelletier L, Balabaud C, Laurent A, Blanc JF, Mazzaferro V, Calvo F, Villanueva A, Nault JC, Bioulac-Sage P, Stratton MR,
Llovet JM, Zucman-Rossi J. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic
targets. Nat Genet 2015;47:505-11.
43. Sebastian C, Satterstrom FK, Haigis MC, Mostoslavsky R. From sirtuin biology to human diseases: an update. J Biol Chem
2012;287:42444-52.
44. You M, Liang X, Ajmo JM, Ness GC. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am J Physiol Gastrointest
Liver Physiol 2008;294:G892-8.
45. Stunkel W, Peh BK, Tan YC, Nayagam VM, Wang X, Salto-Tellez M, Ni B, Entzeroth M, Wood J. Function of the SIRT1 protein
deacetylase in cancer. Biotechnol J 2007;2:1360-8.
46. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W. Negative control of p53 by Sir2alpha promotes cell survival under
stress. Cell 2001;107:137-48.
47. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. Modulation of NF-kappaB-dependent transcription and cell
survival by the SIRT1 deacetylase. EMBO J 2004;23:2369-80.
48. Jang KY, Noh SJ, Lehwald N, Tao GZ, Bellovin DI, Park HS, Moon WS, Felsher DW, Sylvester KG. SIRT1 and c-Myc promote liver
tumor cell survival and predict poor survival of human hepatocellular carcinomas. PLoS One 2012;7:e45119.
49. Mercer KE, Hennings L, Ronis MJ. Alcohol consumption, Wnt/beta-catenin signaling, and hepatocarcinogenesis. Adv Exp Med Biol
2015;815:185-95.
50. Lindenmeyer CC, McCullough AJ. The natural history of nonalcoholic fatty liver disease-an evolving view. Clin Liver Dis 2018;22:11-21.
51. Agosti P, Sabba C, Mazzocca A. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver
microenvironment. Biochim Biophys Acta 2018;1864:607-17.
52. Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, Ahmed A. Nonalcoholic steatohepatitis is the second leading
etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015;148:547-55.